Zhejiang Zhongxin Fluoride Materials Co.,Ltd (002915.SZ)
Shaoxing, CN
Zhejiang Zhongxin Fluoride Materials Co., Ltd (002915.SZ) is a Chinese enterprise dedicated to the research, production, and distribution of advanced fluorine fine chemicals. Its extensive product portfolio encompasses a variety of fluorine-containing compounds, such as cyanobenzene, benzoic acid, phenol, phenylcarbinol, phenylamine, and nitrobenzene. The company also supplies arene series, acetophenone, and heterocyclic ring derivatives, among others. These specialized chemical intermediates are crucial for diverse industrial applications, including pharmaceuticals, agrochemicals, novel materials development, and electronic chemicals. While primarily operating within China, the company also maintains an international sales presence, exporting its goods to key markets like Germany, Japan, and India. Established in Shaoxing, China, in the year 2000, Zhejiang Zhongxin Fluoride Materials Co., Ltd has built a strong foundation in the chemical industry.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -4.14% | -11.84% | +1.44% | -19.71% | -17.12% | -22.53% | -0.84% | +4.92% | +32.91% | +330.39% | +330.39% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2025-07 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+11.9% ★ Q1'26: -12.6% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+110.1% ★ Q1'26: -258.3% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-11.3% Q1'26: -35.4% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+3.4% Q1'26: +2.1% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+2.4% Q1'26: +0.9% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.1% Q1'26: +1.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×4.18× Q1'26: 46.58× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|
| Revenue |
1.34B
est: 1.23B (+9.6%)
|
1.40B
est: 1.42B (-1.0%)
|
1.57B
est: 1.59B (-1.1%)
|
1.84B
1.84B – 1.84B
+15.9% YoY
|
| EBITDA |
126.62M
est: 190.60M (-33.6%)
|
92.41M
est: 197.04M (-53.1%)
|
234.09M
est: 220.80M (+6.0%)
|
255.81M
255.81M – 255.81M
+15.9% YoY
|
| EBIT |
-6.72M
est: 95.80M (-107.0%)
|
-72.42M
est: 75.50M (-195.9%)
|
52.60M
est: 84.61M (-37.8%)
|
98.03M
98.03M – 98.03M
+15.9% YoY
|
| Net Income |
-188.18M
est: 52.07M (-461.4%)
|
-185.53M
est: 100.95M (-283.8%)
|
18.82M
est: 29.31M (-35.8%)
|
74.90M
74.90M – 74.90M
+155.6% YoY
|
| SGA |
118.79M
est: 85.27M (+39.3%)
|
119.55M
est: 90.22M (+32.5%)
|
37.39M
est: 101.10M (-63.0%)
|
117.14M
117.14M – 117.14M
+15.9% YoY
|
| EPS |
-0.57
est: 0.16 (-456.3%)
|
-0.57
est: 0.31 (-283.9%)
|
0.06
est: 0.09 (-35.8%)
|
0.23
0.23 – 0.23
+155.6% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-28 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-27 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-26 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-25 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-22 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 82.0K | 0.39% |
| 2 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 76.7K | 0.29% |
| 3 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 18.7K | 0.28% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Chao Wang | GM & Non-Independent Director | — | male |
| Qi Liang Yuan | Deputy General Manager | — | male |
| Shaolan Yuan | Secretary of the Board, Chief Financial Officer & Non-Independent Director | — | female |
| Yinxin Li | Accounting Supervisor | — | — |
| Yu Chen | Deputy General Manager | — | male |
| Zheng Jun Shi | Deputy General Manager | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 002915.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
